Lexicon Pharmaceuticals (LXRX) Other financing activities (2012 - 2024)
Lexicon Pharmaceuticals (LXRX) reported Other financing activities of -$1000.0 for Q4 2024, up 99.89% quarter-over-quarter from -$906000.0 in Q3 2024.
Lexicon Pharmaceuticals (LXRX) Other financing activities (2012 - 2024) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 5 years of Other financing activities data on file, last reported at -$1000.0 in Q4 2024.
- Other financing activities for Q4 2024 came in at -$1000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$1000.0 (up 99.92% YoY), and the FY2024 annual result was -$1.3 million, changed N/A from the prior year.
- Other financing activities advanced to -$1000.0 in Q4 2024 per LXRX's latest filing, from -$906000.0 in the prior quarter.
- Over five years, Other financing activities peaked at -$1000.0 in Q4 2024 and troughed at -$906000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -906,000.00 |
| Sep 30, 2024 | -906,000.00 |
| Mar 31, 2024 | -400,000.00 |
| Mar 31, 2024 | -400,000.00 |
| Dec 31, 2015 | 9,000.00 |
| Dec 31, 2015 | 9,000.00 |
| Jun 30, 2015 | 78,000.00 |
| Jun 30, 2015 | 78,000.00 |
| Mar 31, 2015 | -17,000.00 |
| Mar 31, 2015 | -17,000.00 |
| Dec 31, 2014 | 27,000.00 |
| Dec 31, 2014 | 27,000.00 |
| Jun 30, 2014 | -27,000.00 |
| Jun 30, 2014 | -27,000.00 |
| Dec 31, 2013 | 85,000.00 |
| Dec 31, 2013 | 85,000.00 |
| Sep 30, 2013 | -111,000.00 |
| Sep 30, 2013 | -111,000.00 |